Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

JCO oncology practice·2026

Same author

Interconnected influences of diet, gut microbiome, and metabolome on cognition across three metabolomics platforms.

Research square·2026

Same author

Astrocyte glucocorticoid receptor signalling restricts neuronal plasticity.

Nature·2026

Same author

Quantifying the case for prevention: disease burden and cost-effective interventions in UK.

Journal of public health (Oxford, England)·2026

Same author

Assessment of Carbon Emission Impact of Semaglutide in Patients With Type 2 Diabetes in the United Kingdom Using an Innovative Modeling Approach.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Same author

An economic model to assess the costs and benefits of workplace mental wellbeing interventions: A flexible tool for employers and decision makers.

PLOS mental health·2026

Same journal

Reply to: A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome: Regarding: MOGAD is the Most Common Cause of Isolated Optic Neuritis in Children.

Annals of clinical and translational neurology·2026

Same journal

A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome.

Annals of clinical and translational neurology·2026

Same journal

Long-Term Neurologic Exam Findings in People Diagnosed and Treated During Acute HIV Infection.

Annals of clinical and translational neurology·2026

Same journal

Integrating Time-Adjusted Imaging Instability Into Functional Outcome Prediction After Intracerebral Hemorrhage: Development and Validation of the HAGIV Score.

Annals of clinical and translational neurology·2026

Same journal

Advancing Stroke Clinical Trials Using Community Engagement and Implementation Science Approaches.

Annals of clinical and translational neurology·2026

Same journal

Clinical and Modifiable Factors Associated With Disability and Relapse in MOGAD: A Multicentre Cohort Study.

Annals of clinical and translational neurology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 10, 2026

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

Visual Recovery Reflects Cortical MeCP2 Sensitivity in Rett Syndrome.

Alex Joseph Simon¹, Nathalie Picard¹, Valeria d'Andrea^2,3

¹Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Annals of Clinical and Translational Neurology

|November 19, 2025

Summary

This summary is machine-generated.

Restoring MeCP2 protein levels in mouse models of Rett syndrome (RTT) reversed visual deficits and improved sensory functions, even after disease onset. Partial restoration of MeCP2 shows therapeutic potential for RTT patients.

Keywords:

MeCP2 Rett syndrome cortical circuits gene therapy sensory deficits visual function

More Related Videos

Direct-Coupled Electroretinogram DC-ERG for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium

Direct-Coupled Electroretinogram DC-ERG for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium

Published on: July 14, 2020

Simultaneous Recording of Electroretinography and Visual Evoked Potentials in Anesthetized Rats

Simultaneous Recording of Electroretinography and Visual Evoked Potentials in Anesthetized Rats

Published on: July 1, 2016

Related Experiment Videos

Last Updated: Jan 10, 2026

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

Direct-Coupled Electroretinogram DC-ERG for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium

Direct-Coupled Electroretinogram DC-ERG for Recording the Light-Evoked Electrical Responses of the Mouse Retinal Pigment Epithelium

Published on: July 14, 2020

Simultaneous Recording of Electroretinography and Visual Evoked Potentials in Anesthetized Rats

Simultaneous Recording of Electroretinography and Visual Evoked Potentials in Anesthetized Rats

Published on: July 1, 2016

Area of Science:

Neuroscience
Genetics
Developmental Biology

Background:

Rett syndrome (RTT) is a neurodevelopmental disorder characterized by regression in motor, sensory, and cognitive functions.
Sensory disruptions, particularly in visual processing, significantly contribute to RTT's complex symptoms.
Current genetic therapies for RTT have shown success in motor and respiratory functions, but their impact on sensory deficits is less understood.

Purpose of the Study:

To investigate the efficacy of restoring MeCP2 expression in reversing visual pathway deficits in mouse models of Rett syndrome.
To explore the potential of genetic medicine-based therapies for addressing sensory impairments in RTT.

Main Methods:

Utilized genetically reversible mouse models (Mecp2^stop/y and Mecp2^stop/x) of MeCP2 deficiency.
Employed advanced electrophysiological, anatomical, and behavioral techniques to assess visual function.
Evaluated the effects of initiating MeCP2 expression at different stages of development and disease progression.

Main Results:

Reactivation of MeCP2 after postnatal day 35 in Mecp2^stop/y mice reversed cortical dysfunction and restored visual function.
Thalamic circuit organization was preserved with MeCP2 restoration, despite some residual cortical abnormalities.
Even in adult Mecp2^stop/x mice with established regression, MeCP2 reactivation significantly reduced symptoms.

Conclusions:

Cortical circuits demonstrate high sensitivity to MeCP2 expression levels throughout development and in mature brains.
Partial restoration (60-70%) of MeCP2 protein levels is sufficient to rescue sensory functions, even post-regression.
These findings support the transformative potential of genetic therapies for RTT, indicating that partial MeCP2 restoration can substantially improve sensory processing and patient quality of life.